Beizo Health Secures Tens of Millions in RMB Angel Funding to Advance Digital Cardio-Cerebrovascular Health Services

Recently, Hangzhou Beizuo Health Technology Co., Ltd. (“Beizuo Health”) announced the completion of its angel financing round, raising tens of millions of RMB. This round was jointly invested by Hangzhou Fenghui Liuheqiao Venture Capital Technology Co., Ltd. and Hangzhou Lihe Linzhuo Angel Venture Capital Partnership (Limited Partnership). The funds will be primarily used to introduce globally advanced early screening and intelligent monitoring devices, accelerate the commercialization of patented technologies in the field of cardiovascular and cerebrovascular health, upgrade its digital health platform, and further explore the application of artificial intelligence in cardiovascular and cerebrovascular health management.

As a digital service platform dedicated to cardiovascular and cerebrovascular health solutions, Beizuo Health has been committed since its establishment in 2023 to integrating global top-tier medical imaging equipment with early screening and intelligent monitoring devices, while leveraging high-quality domestic healthcare resources to provide personalized and precise health management services for individuals at high risk of cardiovascular and cerebrovascular diseases.

As the capital frenzy subsides, Beizuo Health has secured tens of millions in angel financing against the trend, underscoring investors’ strong recognition of the digital health sector for cardiovascular and cerebrovascular diseases and its deterministic opportunities. Cardiovascular and cerebrovascular diseases are the leading cause of death in China, accounting for 4 million deaths annually, or 40% of all deaths. As the “golden generation” of the reform and opening-up era, aged 40–65, enters the high-incidence period for these conditions, a preventive health management market worth hundreds of billions of yuan has emerged.

This round of investment will empower Beizuo Health to continuously enhance its technological capabilities, build a specialized internet hospital for cardiovascular and cerebrovascular diseases, and promote the deep integration of AIGC (Generative AI) large medical models in the cardiovascular and cerebrovascular field. It aims to explore their precise applications in predicting and diagnosing cardiovascular and cerebrovascular diseases, as well as recommending health management plans. This will enable the company to better provide one-stop services—from risk assessment and specialized diagnostic screening to personalized health management solutions—for members who face significant life and work pressures and are willing to invest in high-quality health management services. These efforts will effectively prevent sudden risks such as myocardial infarction, sudden cardiac death, and stroke, thereby ensuring the health and stability of “family breadwinners.”

It is reported that Beizuo Health’s digital membership product for cardiovascular and cerebrovascular health has garnered strong positive feedback since its launch, particularly among senior and middle-level executives in the insurance, internet, banking, and manufacturing sectors across first- and second-tier cities such as Shanghai, Hangzhou, and Guangzhou. Members have experienced significant improvements in their cardiovascular and cerebrovascular health status and risk prevention and control after enrolling in the wellness program.

The core team of Beizuo Health hails from Baidu, AstraZeneca, WeDoctor, and renowned Grade A tertiary hospitals in China, bringing extensive experience in the healthcare industry alongside strong backgrounds in internet technology and artificial intelligence.

Zhang Kuan, Founder and CEO of Beizuo Healthstated: “We are deeply grateful for the investors’ full trust and strong support, which will undoubtedly accelerate our growth and inject powerful momentum into the team’s continuous innovation. Moving forward, Beizuo Health will remain true to its original mission, dedicated to integrating the world’s most advanced cardiovascular and cerebrovascular health technologies with healthcare services. Through our digital health platform, we aim to provide timely and precise cardiovascular and cerebrovascular health solutions to a broader population, building a comprehensive and efficient health protection network for every member.”

As an investor in this round,Ma Haibang, Head of Liuheqiao Venture Capital“The digital health market for cardiovascular and cerebrovascular diseases boasts broad prospects and urgent demand. Leveraging its innovative digital health management solutions and a professional founding team, Beizuo Health is positioned at the forefront of this sector. We are confident in Beizuo Health’s innovations in the field of digital health management for cardiovascular and cerebrovascular conditions, and we look forward to further deepening our collaboration through this round of investment, helping it achieve breakthroughs in product development and market expansion.”

Beizuo Health is a digital health service provider specializing in cardiovascular and cerebrovascular care. By introducing and integrating globally leading early screening tools, intelligent monitoring devices, and cutting-edge medical imaging equipment, and combining them with high-quality domestic healthcare resources, the company delivers more precise and professional digital health solutions for cardiovascular and cerebrovascular conditions to its members. Beizuo Health is committed to providing comprehensive cardiovascular and cerebrovascular health protection for hundreds of millions of families.

Hangzhou Fenghui Liuheqiao Venture Capital is a venture capital firm specializing in early-stage angel investments. Established in 2006, it operates under its proprietary fund brand, the Liuheqiao Venture Capital Fund, and is dedicated to angel investing in sectors such as the digital economy, biomedicine, artificial intelligence, high-end equipment manufacturing, information technology, and integrated circuits. The firm has invested in multiple renowned unicorn companies, including PingPong, eSignbao, and Langxun Technology. It has been honored with numerous awards, including “Zhejiang Province’s Best Angel Investment Institution of 2016,” “Top 10 Angel Investment Institutions in Zhejiang in 2017,” “Top 20 Best Venture Capital Institutions in the Yangtze River Delta Region in 2019,” “Top 10 Outstanding Angel Investment Institutions in Zhejiang in 2020,” and “Zhejiang Outstanding Angel Investment Institution of 2022.”